secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001640334-23-001339
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria granted three US patents for DehydraTECH in hypertension and nicotine delivery
--------------------------------------------------------------------------------

- Issued US Patents #11,666,543 and #11,666,544 for DehydraTECH in treating hypertension.
- Issued US Patent #11,700,875 covering sublingual nicotine delivery via DehydraTECH.
- Plans to file FDA IND for DehydraTECH-CBD for hypertension soon.
- Ongoing study NIC-H22-1 tests DehydraTECH nicotine pouches vs commercial alternatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001339/0001640334-23-001339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001339/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-001339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer